共 41 条
[1]
Fiskum G.(2003)Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson’s disease Acad. Sci. 991 111-119
[2]
Starkov A.(1994)Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson’s disease J. Neurochem. 63 1987-1990
[3]
Polster B.M.(2002)Ironing out Parkinson’s disease: is therapeutic treatment with iron chelators a real possibility? Aging Cell 1 17-21
[4]
Chinopoulos C.(1989)Abnormalities of the electron transport chain in idiopathic Parkinson’s disease Ann. Neurol. 26 719-723
[5]
Hartley A.(2004)High frequency of mitochondrial complex I mutations in Parkinson’s disease and aging Neurobiol. Aging 25 1273-1281
[6]
Stone J.M.(2001)Neurochemical findings in the MPTP model of Parkinson’s disease J. Neural. Transm. 108 1263-1282
[7]
Heron C.(1985)Copper(II) and nickel(II) ternary complexes of L-dopa and related compounds J. Inorg. Biochem. 25 247-259
[8]
Cooper J.M.(1979)Complexes of 3,4-dihydroxyphenyl derivatives. III. Equilibrium study of parent and some mixed ligand complexes of dopamine, alanine and pyrocatechol with nickel(II), copper(II) and zinc(II) ions Pure Appl. Chem. 51 1-20
[9]
Schapira A.H(1979)Complexes of 3,4-dihydroxyphenyl derivatives. II. Complex formation processes in the nickel(II)-L-DOPA and zinc(II)-L-DOPA systems Inorg. Chim. Acta 36 31-36
[10]
Kaur D.(1979)Complexes of 3,4-dihydroxyphenyl derivatives. IV. Equilibrium studies on some transition metal complexes formed with adrenaline and noradrenaline Inorg. Chim. Acta 36 113-120